Bank of New York Mellon’s Ginkgo Bioworks DNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.34M | Buy |
118,787
+92,395
| +350% | +$1.04M | ﹤0.01% | 2942 |
|
|
2025
Q1 | $150K | Buy |
26,392
+3,331
| +14% | +$19K | ﹤0.01% | 3931 |
|
|
2024
Q4 | $226K | Buy |
23,061
+7,503
| +48% | +$73.7K | ﹤0.01% | 3883 |
|
|
2024
Q3 | $127K | Sell |
15,558
-3,863
| -20% | -$31.5K | ﹤0.01% | 3974 |
|
|
2024
Q2 | $260K | Sell |
19,421
-76,528
| -80% | -$1.02M | ﹤0.01% | 3867 |
|
|
2024
Q1 | $4.45M | Sell |
95,949
-15,385
| -14% | -$714K | ﹤0.01% | 2382 |
|
|
2023
Q4 | $7.53M | Buy |
111,334
+7,201
| +7% | +$487K | ﹤0.01% | 2152 |
|
|
2023
Q3 | $7.54M | Buy |
104,133
+2,947
| +3% | +$213K | ﹤0.01% | 2105 |
|
|
2023
Q2 | $7.53M | Buy |
101,186
+19,422
| +24% | +$1.44M | ﹤0.01% | 2094 |
|
|
2023
Q1 | $4.35M | Buy |
81,764
+870
| +1% | +$46.3K | ﹤0.01% | 2382 |
|
|
2022
Q4 | $5.47M | Sell |
80,894
-149
| -0.2% | -$10.1K | ﹤0.01% | 2296 |
|
|
2022
Q3 | $10.1M | Buy |
81,043
+7,278
| +10% | +$908K | ﹤0.01% | 1898 |
|
|
2022
Q2 | $7.02M | Buy |
73,765
+61,136
| +484% | +$5.82M | ﹤0.01% | 2138 |
|
|
2022
Q1 | $2.04M | Sell |
12,629
-440
| -3% | -$70.9K | ﹤0.01% | 2930 |
|
|
2021
Q4 | $4.34M | Buy |
+13,069
| New | +$4.34M | ﹤0.01% | 2539 |
|